Try our Advanced Search for more refined results

Abbott Laboratories v. Grifols Diagnostic Solutions Inc. et al

  1. January 14, 2025

    Abbott, Novartis Settle HIV Test Patent Beef Ahead Of Trial

    Abbott Laboratories, Novartis and Grifols have reached a settlement in a yearslong battle over a patent covering a method for replicating DNA, putting to rest the litigation less than a month before it was set to go to trial, according to an entry in Illinois federal court posted Monday.

  2. September 21, 2023

    Abbott Gets Partial Win In HIV Test Patent Feud With Novartis

    An Illinois federal judge has partly granted a win to Abbott in a suit seeking a finding that it didn't infringe a Novartis patent covering a method for replicating DNA that allegedly was used in its HIV test, but said parts of the patent were valid.

  3. December 19, 2022

    Novartis And Grifols Say Abbott Can't Tank HIV Test Patent

    Novartis and diagnostic testing company Grifols have urged an Illinois federal judge not to ax an HIV test patent at the center of their infringement feud with rival Abbott Laboratories, arguing that Abbott's invalidity arguments fall "well short" of evidentiary standards.

  4. November 22, 2022

    Abbott Tries Again To Sink HIV Test Patent

    Abbott Laboratories says that a Novartis patent covering a method for replicating DNA that allegedly was used in its HIV tests should never have been issued in the first place, since it cites patent paperwork that dates to 1984, when "the scientific community had much to learn about AIDS."

  5. December 02, 2020

    Abbott Can't Escape Infringement Claims Over HIV Testing

    Abbott Laboratories must face allegations that its HIV testing products infringe a patent covering a method for replicating HIV-specific DNA, an Illinois federal judge ruled Tuesday, finding Abbott failed to show the claim was ineligible as a natural phenomenon.